Work

I-97. Clinical benefit in NSCLC: The evidence for Gefitinib (“Iressa”)

Year: 2003

Type: conference-abstract

Source: Lung Cancer

DOI: 10.1016/s0169-5002(03)90504-6

Author: Thomas Lynch

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1965367704

Cites:

Cited by:

Related to: 10